A new study reveals that obesity accelerated Alzheimer's blood biomarkers by 95% over five years, highlighting a strong ...
For the millions of Americans touched by Alzheimer’s disease, 2025 brought major advances in understanding of brain health ...
An estimated seven million in the United States suffer from Alzheimer’s. And there are an estimated 12 million unpaid family ...
MedPage Today on MSN
Alzheimer's benefits may continue after donanemab treatment ends, data suggest
Patients who completed treatment by 12 months fared better than external controls 2 years ...
Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term ...
MedPage Today on MSN
Leading drug fails to slow Alzheimer's progression
Semaglutide lowered inflammation, but not cognitive decline ...
It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...
UD's DementiaBank outshines global competitors, driving machine-learning advances in early dementia prediction ...
Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...
Where you live in Maryland will likely affect your quality of care if you are diagnosed with Alzheimer’s disease, according ...
News-Medical.Net on MSN
Analysis of Alzheimer's disease and related dementias uncovers disparities in Maryland's rural communities
A new statewide spatial analysis of Alzheimer's disease and related dementias (ADRD) has uncovered significant disparities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results